These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Enterococcal bacteremia: clinical features, the risk of endocarditis, and management. Maki DG, Agger WA. Medicine (Baltimore); 1988 Jul; 67(4):248-69. PubMed ID: 3134590 [Abstract] [Full Text] [Related]
23. Infective endocarditis due to penicillin-resistant viridans group streptococci. Knoll B, Tleyjeh IM, Steckelberg JM, Wilson WR, Baddour LM. Clin Infect Dis; 2007 Jun 15; 44(12):1585-92. PubMed ID: 17516402 [Abstract] [Full Text] [Related]
24. [Infective endocarditis due to high level aminoglycoside resistant Enterococcus faecalis and methicillin resistant coagulase-negative staphylococci presenting with rheumatic manifestations]. Pişkin N, Akduman D, Aydemir H, Celebi G, Oztoprak N, Aktaş E. Mikrobiyol Bul; 2008 Jul 15; 42(3):509-14. PubMed ID: 18822897 [Abstract] [Full Text] [Related]
25. Synergistic treatment of enterococcal endocarditis: in vitro and in vivo studies. Serra P, Brandimarte C, Martino P, Carlone S, Giunchi G. Arch Intern Med; 1977 Nov 15; 137(11):1562-7. PubMed ID: 921443 [Abstract] [Full Text] [Related]
26. Antibiotic treatment of staphylococcal septicaemia and endocarditis in a Swedish hospital. Svanbom M. Scand J Infect Dis Suppl; 1983 Nov 15; 41():161-72. PubMed ID: 6589754 [Abstract] [Full Text] [Related]
27. Treatment of experimental endocarditis caused by penicillin-resistant Streptococcus sanguis with different doses of teicoplanin. Martínez F, Martín-Luengo F, García A, Valdés M. Methods Find Exp Clin Pharmacol; 1994 May 15; 16(4):247-51. PubMed ID: 8051983 [Abstract] [Full Text] [Related]
28. [Antibiotic prevention of bacterial endocarditis]. Flückiger U, Malinverni R, Francioli P. Ther Umsch; 1991 Apr 15; 48(4):225-31. PubMed ID: 1858064 [Abstract] [Full Text] [Related]
29. [Treatment with vancomycin of experimental endocarditis caused by Streptococcus sanguis II resistant to penicillin]. Martínez F, Martín Luengo F, Valdés M. Enferm Infecc Microbiol Clin; 1993 May 15; 11(5):255-9. PubMed ID: 8324022 [Abstract] [Full Text] [Related]
30. The role of vancomycin in the treatment paradigm. Stevens DL. Clin Infect Dis; 2006 Jan 01; 42 Suppl 1():S51-7. PubMed ID: 16323121 [Abstract] [Full Text] [Related]
31. Pathogenesis and treatment of enterococcal infections. Gross MH, Barriere SL. Clin Pharm; 1984 Jan 01; 3(2):161-6. PubMed ID: 6373101 [Abstract] [Full Text] [Related]
32. Antibiotic prophylaxis and prosthetic valve endocarditis. Antunes MJ, Sanches MF, Fernandes LE. J Heart Valve Dis; 1992 Nov 01; 1(2):201-5. PubMed ID: 1341628 [Abstract] [Full Text] [Related]
33. Endovascular infections arising from right-sided heart structures. Remetz MS, Quagliarello V. Cardiol Clin; 1992 Feb 01; 10(1):137-49. PubMed ID: 1739955 [Abstract] [Full Text] [Related]
34. Combination antibiotic therapy for infective endocarditis. Le T, Bayer AS. Clin Infect Dis; 2003 Mar 01; 36(5):615-21. PubMed ID: 12594643 [Abstract] [Full Text] [Related]
35. [Surgery for bacterial endocarditis. When?]. Acar J, Michel PL. Arch Mal Coeur Vaiss; 1993 Dec 01; 86(12 Suppl):1863-7. PubMed ID: 8024392 [Abstract] [Full Text] [Related]
36. The use of beta-lactam antibiotics in the treatment of septicaemia and endocarditis. Watanakunakorn C. Scand J Infect Dis Suppl; 1984 Dec 01; 42():110-6. PubMed ID: 6442009 [Abstract] [Full Text] [Related]
37. [Antibiotic prevention of bacterial endocarditis]. Brubakk O, Bruun JN, Hovig B, Andrew M, Eskerud J, Skoglund LA. Tidsskr Nor Laegeforen; 1992 Feb 10; 112(4):466-71. PubMed ID: 1553692 [Abstract] [Full Text] [Related]
39. [Survey of infective endocarditis in the last 10 years: analysis of clinical, microbiological and therapeutic features]. Sekido M, Takano T, Takayama M, Hayakawa H. J Cardiol; 1999 Apr 10; 33(4):209-15. PubMed ID: 10225203 [Abstract] [Full Text] [Related]